By analyzing in silico samples from patients with GBM of the TCGA database, Cai et al. first described that TSPO is highly expressed in the prognostically unfavorable mesenchymal GBM transcriptional subtype [14]. The gene discussed is TSPO; the disease is glioblastoma.